Literature DB >> 29417361

Sexually Transmitted Diseases Among Pregnant Women: 5 States, United States, 2009-2011.

Charnetta L Williams1,2, Leslie L Harrison3, Eloisa Llata4, Ruben A Smith3, Elissa Meites4.   

Abstract

Introduction Screening for specific sexually transmitted diseases (STDs) during pregnancy has been a longstanding public health recommendation. Prior studies have described associations between these infections and socioeconomic factors such as race/ethnicity and education. Objectives We evaluated the prevalence of STDs and the correlation socioeconomic factors have with the presence of these infections among pregnant women in the United States. Methods We conducted an analysis using self-reported data from 12,948 recently pregnant women from the Pregnancy Risk Assessment Monitoring System (PRAMS) in 5 states during 2009-2011. Responses to questions about curable STDs (chlamydia, gonorrhea, syphilis, trichomoniasis) diagnosed during pregnancy were utilized to calculate weighted STD prevalence estimates and 95% confidence intervals (CI). A logistic regression was also conducted to identify maternal socioeconomic characteristics significantly associated with STDs; results are displayed as adjusted prevalence ratios (aPR). The PRAMS protocol was approved at PRAMS participating sites and by CDC's Institutional Review Board. Results Overall, 3.3% (CI 2.9-3.7) reported ≥ 1 curable STD during her most recent pregnancy. The adjusted STD prevalence was higher among women with younger age (aPR, 2.4; CI 1.8-3.4), non-Hispanic black race/ethnicity (aPR, 3.3; CI 2.4-4.1), unmarried status (aPR, 2.1; CI 1.4-3.0), no college education (aPR, 1.4; CI 1.0-1.9), annual income < $25,000 (aPR, 2.0; CI 1.3-3.2), and no pre-pregnancy health insurance (aPR, 1.4; CI 1.1-1.8). Conclusions for Practice This is the largest study of prevalence of self-reported curable STDs among U.S. pregnant women. Differences in STD prevalence highlight the association between certain socioeconomic factors and the presence of STDs.

Entities:  

Keywords:  Pregnancy Risk Assessment Monitoring System (PRAMS); Pregnant women; Sexually transmitted diseases/sexually transmitted infections; Socioeconomic factors

Mesh:

Year:  2018        PMID: 29417361      PMCID: PMC5857256          DOI: 10.1007/s10995-017-2422-9

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  37 in total

1.  Chlamydial and gonococcal testing during pregnancy in the United States.

Authors:  Amy J Blatt; Jay M Lieberman; Donald R Hoover; Harvey W Kaufman
Journal:  Am J Obstet Gynecol       Date:  2012-04-30       Impact factor: 8.661

2.  The Pregnancy Risk Assessment Monitoring System (PRAMS): current methods and evaluation of 2001 response rates.

Authors:  Holly B Shulman; Brenda Colley Gilbert; Coi Gl Msphbrenda; Amy Lansky
Journal:  Public Health Rep       Date:  2006 Jan-Feb       Impact factor: 2.792

3.  The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth.

Authors:  W W Andrews; R L Goldenberg; B Mercer; J Iams; P Meis; A Moawad; A Das; J P Vandorsten; S N Caritis; G Thurnau; M Miodovnik; J Roberts; D McNellis
Journal:  Am J Obstet Gynecol       Date:  2000-09       Impact factor: 8.661

4.  Postpartum sexually transmitted disease: refining our understanding of the population at risk.

Authors:  Rebekah Wheeler; Valerie A Earnshaw; Trace Kershaw; Jeannette R Ickovics
Journal:  Sex Transm Dis       Date:  2012-07       Impact factor: 2.830

5.  Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation.

Authors:  E O Laumann; Y Youm
Journal:  Sex Transm Dis       Date:  1999-05       Impact factor: 2.830

6.  Current or past physical or sexual abuse as a risk marker for sexually transmitted disease in pregnant women.

Authors:  Pamela Jo Johnson; Wendy L Hellerstedt
Journal:  Perspect Sex Reprod Health       Date:  2002 Mar-Apr

7.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

8.  The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008.

Authors:  Kwame Owusu-Edusei; Harrell W Chesson; Thomas L Gift; Guoyu Tao; Reena Mahajan; Marie Cheryl Bañez Ocfemia; Charlotte K Kent
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

9.  Syphilis Infection during pregnancy: fetal risks and clinical management.

Authors:  Marco De Santis; Carmen De Luca; Ilenia Mappa; Terryann Spagnuolo; Angelo Licameli; Gianluca Straface; Giovanni Scambia
Journal:  Infect Dis Obstet Gynecol       Date:  2012-07-04

10.  Gonorrhea infection in women: prevalence, effects, screening, and management.

Authors:  Cheryl K Walker; Richard L Sweet
Journal:  Int J Womens Health       Date:  2011-07-19
View more
  10 in total

1.  Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.

Authors:  Katherine Kortsmit; Letitia Williams; Karen Pazol; Ruben A Smith; Maura Whiteman; Wanda Barfield; Emilia Koumans; Athena Kourtis; Leslie Harrison; Brenda Bauman; Lee Warner
Journal:  JAMA Pediatr       Date:  2019-07-01       Impact factor: 16.193

2.  Prevalence trends and risk factors associated with HIV, syphilis, and hepatitis C virus among pregnant women in Southwest China, 2009-2018.

Authors:  Shanmei Zhong; Yanyun Ou; Fei Zhang; Zhaosen Lin; Rongye Huang; Aidan Nong; Zhenxian Wu; Huayue Liang; Cai Qin; Qiuyu Wei; Yuan Yang; Dee Yu; Xianyan Tang; Li Ye; Deping Liu; Hao Liang; Bingyu Liang
Journal:  AIDS Res Ther       Date:  2022-06-27       Impact factor: 2.846

3.  Sexually transmissible infection testing among pregnant women in the US, 2011-15.

Authors:  Jami S Leichliter; Laura T Haderxhanaj; Thomas L Gift; Patricia J Dittus
Journal:  Sex Health       Date:  2020-02       Impact factor: 2.706

Review 4.  Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges.

Authors:  Andreea Waltmann; Tyler R McKinnish; Joseph A Duncan
Journal:  Curr Opin Infect Dis       Date:  2021-02-01       Impact factor: 4.915

5.  Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

Authors:  Luis M de la Maza; Toni L Darville; Sukumar Pal
Journal:  Expert Rev Vaccines       Date:  2021-04-28       Impact factor: 5.217

6.  Utility of Routine Testing for Chlamydia and Gonorrhea in the Setting of Preterm Delivery or Premature Preterm Rupture of Membranes.

Authors:  Kaitlynn Ebisutani; Charlie K Wang; Hyeong Jun Ahn; Autumn J Broady; Bliss Kaneshiro
Journal:  Hawaii J Health Soc Welf       Date:  2021-06

7.  HIV Status and Other Risk Factors for Prevalent and Incident Sexually Transmitted Infection during Pregnancy (2000-2014).

Authors:  Jodie Dionne-Odom; Michelle J Khan; Victoria C Jauk; Jeff Szychowski; Dustin M Long; Suzanne Wallace; Cherry Neely; Karen Fry; Jeanne Marrazzo; Marilyn Crain; Alan T N Tita
Journal:  Infect Dis Obstet Gynecol       Date:  2019-04-01

8.  High rates of persistent and recurrent chlamydia in pregnant women after treatment with azithromycin.

Authors:  Jodie Dionne-Odom; Akila Subramaniam; Kristal J Aaron; William M Geisler; Alan T N Tita; Jeanne Marrazzo
Journal:  Am J Obstet Gynecol MFM       Date:  2020-08-18

9.  Chlamydia Prevalence by Age and Correlates of Infection Among Pregnant Women.

Authors:  Janice Leahgrace Simons; Jessica S McKenzie; Nicole C Wright; Shainela A Sheikh; Akila Subramaniam; Alan T N Tita; Jodie Dionne-Odom
Journal:  Sex Transm Dis       Date:  2021-01       Impact factor: 3.868

10.  Sexually transmitted infection associated syndromes among pregnant women attending antenatal care clinics in southwest Ethiopia.

Authors:  Tewodros Yosef
Journal:  Heliyon       Date:  2021-07-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.